Cymbalta

DRUG4 trials

Sponsors

National Taiwan University Hospital, Dr. Jesus Gutierrez Stone, Boehringer Ingelheim, Hospital for Special Surgery, New York

Conditions

Joint DiseasePainPain, AcutePain, ChronicSchizophreniaSystemic Lupus Erythematosus

Phase 4

Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype

National Taiwan University HospitalSchizophrenia

Start: 2010-02-28End: 2011-01-31Target: 75Updated: 2010-03-10

Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty

CompletedNCT03271151

Hospital for Special Surgery, New YorkJoint Disease, Pain, Acute, Pain, Chronic

Start: 2017-09-28End: 2021-02-19Updated: 2024-12-27

Unknown Phase

Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus

CompletedNCT01269866

Dr. Jesus Gutierrez StoneSystemic Lupus Erythematosus

Start: 2010-12-31End: 2012-05-31Updated: 2013-02-05

Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

CompletedNCT02215798

Boehringer IngelheimPain

Start: 2006-07-31Updated: 2014-08-22